Table 1 Baseline characteristics of participants
|  | Haemodialysis (n = 50) | Peritoneal dialysis (n = 50) | Conservative management (n = 50) | Conservative management stage 5 (n = 31) |
|---|---|---|---|---|
Age (years) | 45.5 ± 12.3 | 44.1 ± 11.6 | 59.0 ± 13.5 | 59.9 ± 14.1 |
Sex | Male: 23 (46%) | Male: 25 (50%) | Male: 27 (54%) | Male: 14 (45.2%) |
Female: 27 (54%) | Female: 25 (50%) | Female: 23 (46%) | Female: 17 (54.8%) | |
Race | African: 37 (75%) | African: 34 (68%) | African: 33 (66%) | African: 19 (61.1%) |
Asian: 3 (6%) | Asian: 2 (4%) | Asian: 0 (0%) | Asian: 2 (6.5%) | |
Mixed race: 9 (18%) | Mixed race: 8 (16%) Caucasian: | Mixed race: 14 (28%) | Mixed race: 6 (19.4%) | |
Caucasian: 1 (2%) | 6(12%) | Caucasian: 3 (6%) | Caucasian: 4 (12.9%) | |
Relationship status | Married: 14 (28%) | Married: 19 (38%) | Married: 21 (42%) | Married: 10 (32.3%) |
Partner: 9 (18%) | Partner: 5 (10%) | Partner: 3 (6%) | Partner: 2 (6.4%) | |
None: 27 (54%) | None: 26 (52%) | None: 26 (52%) | None: 19 (61.3%) | |
Source of income | Unemployed: 47 (94%) | Unemployed: 42 (84%) | Unemployed: 38 (76%) | Unemployed: 25 (80.6%) |
Social grant: 37 (74%) | Social grant: 21 (42%) | Social grant: 29 (58%) | Social grant: 17 (54.8%) | |
Dialysis vintage (months) | 47 [15–82] | 24 [13–40] | – | – |
Access in HD patients / PD modality | Tunneled cuffed catheter: 31 (62%) | CAPD: 45 (90%) | – | – |
Arteriovenous Fistula: 14 (28%) | CCPD: 5 (10%) | |||
Arteriovenous graft: 5(10%) | ||||
Comorbidities | Diabetic: 11 (22%) | Diabetic: 8 (16%) | Diabetic: 25 (50%) | Diabetic: 14 (45.2%) |
HIV positive: 11 (22%) | HIV positive: 10 (20%) | HIV positive: 11 (22%) | HIV positive: 7 (22.6%) | |
Cardiovascular disease: 48 (96%) | Cardiovascular disease: 43 (86%) | Cardiovascular disease: 47 (94%) | Cardiovascular disease: 31 (100%) | |
Hemoglobin (g/dL) | 9.5 [8.7–10.0] | 10.9 [9.3–12.6] | 11.3 [9.6–12.8] | 11.1 [9.4–12.8] |
rEPO dose (units/month) | 40,000 [24,000–64,000] | 32,000 [0–48,000] | –* | – |
Urea (mmol/L) | 19.0 [11.8–26.1] | 20.8 [15.9–25.5] | 20.1 [15.8–27.3] | 21.6 [16.9–30.5] |
Calcium (mmol/L) | 2.22 [2.13–2.40] | 2.20 [2.09–2.30] | 2.27 [2.14–2.37] | 2.28 [2.10–2.36] |
Phosphate (mmol/L) | 1.71 [1.26–2.40] | 1.76 [1.15–2.6]) | 1.38 [1.07–1.66] | 1.48 [1.20–1.72] |
Albumin (g/L) | 40 [36–42] | 35 [30–38] | 40 [37–44] | 40.0 [37–44] |
Parathyroid hormone (ng/mL) | 34.4 [14.8–59.8] | 48.2 [29.6–79] | 15.1 [8.7–21.5] | 18.4 [10.8–21.5] |